Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana 46202


Purpose:

This study will assess whether the presence of a particular form of a gene, GABRA2, affects the functional responses of the human brain to alcohol administration and will evaluate that relationship in the context of factors known to increase the risk for future alcoholism.


Criteria:

Inclusion Criteria: - European American male and females between 21-27 years of age. - Good health as determined by medical history, physical exam, and laboratory tests. - Females must have a negative urine pregnancy (hCG) test at the start of each study session. - People who consume 0.10 standard drinks per week (12 g-ethanol) per liter of total body water when averaged over the preceding month, or more, OR who have consumed more than 0.10 standard drinks per liter of total body water on any one occasion in the last month. Exclusion Criteria: - Inability to read or comprehend eighth grade English. - Inability to hear or comprehend verbal instructions, or inability or unwillingness to cooperate with the procedures required for the study. - Inability to resolve 2 dots, each 2 mm in diameter with centers placed 5 mm apart on a card placed 20 inches from the bridge of the nose, or the need to wear eyeglasses to do so. - Current or prior history of any serious disease, including head trauma causing loss of consciousness, cancer, CNS, cardiovascular, respiratory, gastrointestinal, hepatic, renal, endocrine, or alcohol or drug dependence, but not alcohol abuse or nicotine dependence. - Positive hepatitis or HIV test at screening, provided subject consented to these tests. - Current or prior history of alcohol-induced flushing reactions. - Current diagnosis of Axis-I psychiatric illness. - Positive result on urine drug screen obtained at the face-to-face interview. - Pregnancy, as determined by urine HcG on each day of laboratory testing, or intention to become pregnant for women. - Use of medications known to interact with alcohol within 2 weeks of the study.


NCT ID:

NCT00681655


Primary Contact:

Study Director
Martin H Plawecki, M.D.
Indiana University School of Medicine


Backup Contact:

N/A


Location Contact:

Indianapolis, Indiana 46202
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 18, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.